Edge Therapeutics Announces Appointment Of Renu Vaish, M.S. As Vice President, Regulatory Affairs

Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming the treatment of acute, life-threatening neurological conditions, today announced that Renu Vaish, M.S. has been appointed Vice President, Global Regulatory Affairs, effective January 5, 2015. Ms. Vaish will direct the Company’s worldwide regulatory strategy and initiatives and will report directly to Edge’s Chief Executive Officer, Brian Leuthner.

Help employers find you! Check out all the jobs and post your resume.